Development and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Dapagliflozin, Metformin Hydrochloride, and Vildagliptin in a Fixed-Dose Combination Tablet
International Journal of Drug Delivery Technology · 30.07.2026 · 16 (71s)
DOI: 10.25258/ijddt.16.71s.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 30.07.2026. Verfasst von Swati Saxena und 1 weiteren Autor:innen.
Abstract (Originalsprache)
.
Zitieren
APA
Saxena, S., & Jain, S. K. (2026). Development and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Dapagliflozin, Metformin Hydrochloride, and Vildagliptin in a Fixed-Dose Combination Tablet. International Journal of Drug Delivery Technology, 16(71s). https://doi.org/10.25258/ijddt.16.71s.1
Vancouver
Saxena S, Jain SK. Development and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Dapagliflozin, Metformin Hydrochloride, and Vildagliptin in a Fixed-Dose Combination Tablet. International Journal of Drug Delivery Technology. 2026;16(71s). doi:10.25258/ijddt.16.71s.1
BibTeX
@article{Saxena2026,
author = {Saxena, Swati and Jain, Sachin Kumar},
title = {Development and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Dapagliflozin, Metformin Hydrochloride, and Vildagliptin in a Fixed-Dose Combination Tablet},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {71s},
doi = {10.25258/ijddt.16.71s.1}
}
EUVIMED